Parent-led interventions in reducing infant vaccination pain after participation in a longitudinal randomized control trial by McNair, Caitlin et al.
Paediatrics & Child Health, 2017, 217–219
doi: 10.1093/pch/pxx040
Short Report
Advance Access publication 27 April 2017
©The Author 2017. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved.  
For permissions, please e-mail: journals.permissions@oup.com
217
Short Report
Parent-led interventions in reducing infant vaccination pain after 
participation in a longitudinal randomized control trial
Caitlin McNair, BA1, Many Fung, PharmD1, Anna Taddio, BScPhm MSc PhD1, Moshe Ipp, MD2, Steven Moss, MD3, 
Stephen Baker, MD3, Jonathan Tolkin, MD3, Malini Dave, MD3, Sharmeen Feerasta, MD3, Preeya Govan, MD3, 
Rebecca Pillai Riddell, PhD4
1Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario; 2Paediatric Associates, Toronto, Ontario; 3Private 
Practice, Toronto, Ontario; 4Department of Psychology, Faculty of Health York University, Toronto, Ontario
Correspondence: Anna Taddio, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 
3M2. Telephone 416-978-8822, fax 416-978-1833, e-mail: anna.taddio@utoronto.ca
Keywords:  Analgesia; Immunization; Pain; Vaccination.
INTRODUCTION
Evidence is accumulating on the negative short- and long-term ramifications 
associated with poorly mitigated vaccine injection pain in infants including high 
levels of infant and parental distress, dissatisfaction with the vaccination experi-
ence, development of needle fears, and future noncompliance with immuniza-
tion and other health care interventions involving needles (1). The use of pain 
mitigation interventions is therefore clinically important and considered by the 
World Health Organization to be part of good immunization practice (2). At 
present, utilization of pain mitigation strategies during vaccination is subop-
timal (3). We sought to examine parental patterns of pain mitigation strategy 
utilization during vaccination in infants after participation in a vaccination anal-
gesic trial whereby parents learned about and had experience using a variety of 
different analgesic strategies (4). The primary research question was: What is 
the rate of uptake of analgesic strategies by parents during childhood vaccina-
tions after participation in the trial?
METHODS
We conducted a prospective, observational study including parent–infant dyads 
who participated in a longitudinal randomized controlled trial of analgesia for 
infant vaccination injections. The details of the methodology for the random-
ized controlled trial are reported elsewhere (4). Briefly, infants were random-
ized to four different analgesic regimens of increasing intensity for 2-, 4-, 6- and 
12-month vaccinations: 1) standard care (placebo control), 2) parent-directed 
educational video (video) with information about acting calm, cuddling and 
distracting infants, 3) video and oral sucrose solution (sucrose), and 4) video 
and sucrose and liposomal lidocaine cream (lidocaine). In all groups, procedural 
techniques to minimize pain were used including injecting without aspiration, 
and injecting the most painful vaccine last (4). Treatments were given in the clin-
ics of seven participating paediatricians in a blinded manner. Randomization was 
performed offsite by the research pharmacy at The Hospital for Sick Children 
using a computer randomization table and allocation was concealed using a 
matched placebo for all interventions (i.e., double-dummy design) (4). At the 
15-month vaccination, all infants received all the active interventions in an open 
manner. Parents were then informed about how to make sucrose solution and 
where to purchase topical anesthetics for future vaccinations as they were not 
available at the clinics after the 15-month vaccination.
At the 18-month vaccination, parents self-directed the analgesic interventions 
used, as per usual practices at the study clinics. Research assistants documented 
whether parents continued to use any of the pain mitigation strategies included 
in the trial. For the intervention ‘acting calm’, research assistants observed par-
ent–infant interactions such as positive affect, coping-promoting behaviours 
and deep breathing. Parents also completed an exit survey (Box 1). The parental 
Box 1. Questions asked in the  
parent exit survey
1. How much stress do you feel right now about your infant getting an 
immunization injection on a scale of 0 to 10, where 0 is no stress and 10 
is the worst stress possible?
2. How confident are you in your ability to manage your child’s pain today 
on a scale of 0 to 10, where 0 is not at all confident and 10 is completely 
confident?
3. What methods did you use to try to make your baby’s vaccine injec-
tion(s) less painful today?
4. Can you explain why you chose to do these things?
5. How satisfied are you with how well your baby’s needle pain was con-
trolled today on a scale of 0 to 10, where 0 is not at all satisfied and 10 is 
the most satisfied possible?
6. Is there anything else you wanted to do but didn’t?
a. Sugar water and reason(s) why it was not used
b. Numbing cream and reason(s) why it was not used
c. Techniques suggested in the study video? (e.g., holding, distraction, 
acting calm)
7. What was your most favourite part of this study?
8. What was your least favourite part of this study?
9. Is there any other feedback you would like to provide to us?
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responses to the survey and their pattern of use of different pain mitigation strat-
egies at the 18-month vaccination were summarized descriptively.
RESULTS
Altogether, 130 parents participated out of 352 (44%) originally enrolled in the 
randomized controlled trial. Attrition occurred because the study began after 
the randomized controlled trial was already underway and participants were 
missed (n = 138), there were withdrawals from the randomized controlled trial 
(n = 48) and parents refused to participate (n = 36). We compared the char-
acteristics of infants that were included and excluded, including frequency of 
male sex (52% versus 56%) and number of siblings (59% for both) and found 
no significant differences (P > 0.05).
Demographic characteristics of participating infants are shown in Table  1. 
Altogether, 98.5% of parents held the infant close and acted calm during the 
injection, 73.1% distracted the infant, 13.1% used a pacifier and 8.5% used a 
topical anesthetic to numb the skin (Figure 1). Oral sucrose solution was never 
used. The mean parental satisfaction score (using verbal numerical rating scale: 
range 0 to 10)  for pain management during vaccination was 8.7 (SD  =  1.9), 
parental stress was 1.8 (SD  =  2.5) and confidence in ability to control their 
infants’ pain was 7.1 (SD = 2.5).
Parents who did not utilize topical anesthetics or sucrose most commonly 
reported that they did not find these interventions to be necessary, they did not 
think of them, or that they should be provided by the clinic (Table 2). The most 
common parental response for favourite part of the study was learning about 
and using methods for pain management (43.8%) and for least favourite part, it 
was the needle and witnessing their infant in pain (11.5%).
DISCUSSION
These results reveal some uptake of pain mitigation interventions by parents 
after participation in an analgesic randomized controlled trial. Relative to other 
surveys of pain mitigation intervention utilization during vaccination in our 
community (3), these results appear qualitatively higher, suggesting a beneficial 
effect of participation in the trial (4).
The results also demonstrate that parents commonly used nonpharma-
cological methods such as holding, distracting and acting calm. Parents used 
pharmacological methods of controlling pain such as topical anesthetics or 
oral sucrose less frequently. A  similar pattern of results has been observed in 
other studies and may reflect the feasibility of nonpharmacological methods 
compared to pharmacological methods and preferences of parents to employ 
nonpharmacological approaches (5). Parents indicated that topical anesthetics 
and oral sucrose solution would be utilized more if they were provided by the 
clinic. Making these strategies more accessible and convenient for parents to 
use may lead to higher utilization rates. Separately, there are data demonstrating 
that both sucrose and topical anesthetics can be accommodated within usual 
clinic waiting times and that parents are willing to pay for pain relief (4,6).
Parental satisfaction with their infants’ pain management was also qual-
itatively high, supporting previous research showing when pain mitigation is 
offered, parents report better satisfaction with medical care (7). Giving parents 
a role in managing their infant’s pain may give them a sense of control, which 
in turn, contributes to improved satisfaction with the immunization appoint-
ment. This is significant as endorsing more positive immunization experiences 
can promote future adherence with the immunization schedule and increased 
confidence in health care providers (8).
Parents were unaware of the treatments provided to their infants between 
2 and 12 months, which may have contributed to their uncertainty regarding 
the effectiveness of the individual interventions they expressed at 18 months 
and lack of use of individual interventions. However, the main findings of the 
randomized controlled trial also demonstrated less than compelling results with 
respect to effectiveness of the tested interventions. Significant analgesic effects 
were only demonstrated for the infants allocated to the video and sucrose and 
lidocaine group compared to all other groups, suggesting that only the lidocaine 
component of the pain interventions was effective. Moreover, the magnitude of 
effect was modest (effect size = 0.5) (4). Detecting this difference clinically may 
be challenging for both parents and clinicians, and may not be visible if assessed 
using dichotomous markers of infant distress such as the presence or absence 
of infant crying.
There are some limitations worthy of discussion. Firstly, a significant 
proportion of parents that participated in the randomized controlled trial 
were excluded, which may introduce sampling bias. There was no evidence, 
however, of a difference in the characteristics of those that participated 
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Figure 1. Pain management interventions used by parents during 18-month child vaccination (n = 130).
Table 1. Characteristics of infants (n = 130)
Characteristic Mean (SD) or frequency (%)
Age, months 18.6 (1.1)
Sex, no. male 68 (52)
Race, no. Caucasian 66 (51)
Siblings, no. with 1 or more 77 (59)
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versus those that did not. Secondly, the lack of a control group prevents 
definite conclusions about the impact of prior participation in the ran-
domized controlled trial on utilization of pain interventions. Given that 
the majority of parents cited using the pain strategies because they learned 
about them in the study and had experience with them suggests that partic-
ipation in the trial positively affected uptake of interventions. For topical 
anesthetics specifically, all parents reported that learning about them in the 
study and having experience with them were the reasons for their use at the 
18-month vaccination.
As a result of these findings, we recommend health care providers take an 
active role in facilitating pain mitigation during vaccination by educating par-
ents about evidence-based interventions, making them available for use, and 
coaching parents in their use.
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Table 2. Reasons given by parents for not using sucrose solution or topical 
anesthetics
Sucrose solution, 
n = 130*
Topical anesthetic, 
n = 119*
Did not think it was necessary† 59 (45.4) 49 (41.1)
Forgot/didn’t think about it 37 (28.5) 34 (28.6)
Not provided by clinic/doctor/study 13 (10) 18 (15.1)
Too busy 10 (7.7) 8 (6.7)
Didn’t think it was effective 8 (6.2) 6 (5.0)
Insufficient knowledge on how to  
implement (i.e., make/acquire/use)
4 (3.1) 6 (5.0)
Other 5 (3.8)‡ 4 (3.4)§
No reason given 5 (3.8) 5 (4.2)
Values are frequency (%). *n = 13 parents provided more than one reason for why they 
did not use sucrose solution; n = 12 parents provided more than one reason why they did 
not use topical anesthetics; †Parents sometimes said the intervention was not necessary 
because the pain was minor or, alternatively, because a different pain intervention was used 
instead; ‡n = 3 child does not like/refuses sucrose solution; n = 2 did not know vaccination 
injections were to be administered on that day; §n = 3 did not know vaccination injections 
were to be administered on that day; n = 1 skin reaction at 15-month vaccination
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